Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

AHA 2024 Insights: Considerations in Care of Patients with Cancer: P…

AHA 2024 Insights

Y. Bryce

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

How the Experts Manage: Cardiotoxicity and IO in NSCLC

MI&T Congressi

J. Remon Masip

Cardiotoxicity: Anthracyclines

Scripps Health

M. Davis

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

ACC 2024 Insights

J. Johnson

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Total Health

I. Rhea

Cardiotoxicity in Melanoma – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardiotoxicity in RCC – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardiac Disease in Breast Cancer: Background & Risk Factors

Total Health

I. Rhea

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

Cardio-Oncology: Immune Checkpoint Inhibitor Associated Myocarditis

UCLA Health

E. Yang

2024 Updates on Carcinoid Heart Disease

North American Neuroendocrine Tumor Society

A. Nohria

Cardio-Oncology in Breast Cancer: Treatment Options for Immune Check…

Total Health

I. Rhea

ADT for Prostate Cancer and Cardiovascular Health Considerations

Andrew Hahn

General Approach to Cardio-Oncology in Breast Cancer

Total Health

I. Rhea

ESC 2024 Insights: 2022 ESC Guidelines on Cardio-Oncology: What Do t…

ESC 2024 Insights

R. Asteggiano

Masonic Cancer Center Cardio-Oncology Updates

Masonic Cancer Center, University of Minnesota

S. Konety

ACC 2024 Insights: PROACT - Can We Prevent Chemotherapy-Related Hear…

ACC 2024 Insights

D. Austin